![](/img/cover-not-exists.png)
Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults Living with HIV-1: A Canadian Cost-Utility Analysis
Arthurs, E, Ward, T, Darlington, O, Sugrue, D, Martin, AA, Cartier, SE, Lee, A, Becker, DL, Punekar, YS, McEwan, PVolume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.04.044
Date:
May, 2018
File:
PDF, 106 KB
english, 2018